The HPV vaccine reduces risk of cancer for all, not just women, new data show—so why isn't everyone rushing to get it?

The HPV vaccine reduces risk of cancer for all, not just women, new data show—so why isn't everyone rushing to get it?

A nationwide goal is to have 80% of teens vaccinated against HPV by 2030. Currently, however, in the U.S., just below 63% of adolescents ages 13 to 17 are up to date on this vaccine. New York state is slightly higher at 69%. "There is a need to get the word out about this vaccine," Rand said."It's very effective and very safe, and it prevents cancer."The vaccine prevents infection of several HPV subtypes, including HPV-16 and HPV-18, which causes 70% of cervical cancer as well as other cancers in the genital area, and more rarely, in the throat or tongue.

The U.S. Advisory Committee on Immunization Practices recommends that people up to age 26 who did not receive the vaccine earlier should still get it. Adults ages 27 to 45 should discuss the vaccine with their doctors, as certain populations are more likely to benefit than others. Learn more.Vaccine hesitancy in the U.S. is a problem, despite compelling evidence that the HPV vaccine is safe and effective, Rand said.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

HPV Vaccines Prevent Cancer in Men as Well as Women, New Research SuggestsNew research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States.
Source: TIME - 🏆 93. / 53 Read more »